Posts Tagged ‘Barrett D. DiPaolo’
Sichenzia Ross Ference Carmel LLP Represents BioSig Technologies, Inc. in $3 Million Registered Direct Offering
Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in $40 Million Common Stock Offering and Nasdaq Uplisting of Serve Robotics Inc.
Sichenzia Ross Ference Carmel LLP Represents ThinkEquity LLC and Laidlaw & Company (UK) Ltd. in $8 Million Initial Public Offering of Common Stock of Perfect Moment Ltd.
Sichenzia Ross Ference LLP Represents Spartan Capital Securities, LLC In $2.2 Million Registered Offering For Ault Alliance, Inc.
Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $1.3 Million Underwritten Public Offering for SciSparc Ltd.
Sichenzia Ross Ference LLP Represents Laidlaw & Company (UK) Ltd. in Pricing of The NFT Gaming Company, Inc.’s $7 Million Initial Public Offering
Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $8 Million Underwritten Public Offering of BiondVax Pharmaceuticals Ltd.
Press Release – New York, NY – December 21, 2022 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole book running manager in the $8 Million underwritten public offering of BiondVax Pharmaceuticals, a biotechnology company which focuses on developing, manufacturing, and commercializing innovative immunotherapeutic products. The offering consisted of 1,600,000…
Read MoreSichenzia Ross Ference LLP Represents Laidlaw & Company (UK) Ltd. in $2.3 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants of Amesite Inc.
Press Release – New York, NY – September 1, 2022 – Sichenzia Ross Ference LLP announced today that it represented Laidlaw & Company (UK) Ltd. as sole placement agent for Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets, in a registered direct offering…
Read MoreSichenzia Ross Ference LLP Represents Aegis Capital Corp. in $8 Million Simultaneous Registered Direct Offering and Private Placement of Securities of Kaspien Holdings Inc.
Sichenzia Ross Ference LLP Represents Relmada Therapeutics, Inc. in $100 Million At-The-Market Offering Facility
